Clinical Trial

A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical research study is to gather information about the quality of life benefits of cancer patients with intermediate risk PE who underwent thrombectomy. The safety of thrombectomy in this patient population will also be studied.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-19.
Status change: Not Yet Recruiting → Recruiting 2026-01-29
Trial Details
NCT Number NCT07298096
Lead Sponsor M.D. Anderson Cancer Center
Conditions Cancer
Enrollment 25 participants
Start Date 2026-01-08
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-29